Henrik Hjalgrim spends much of his time researching Internal medicine, Risk factor, Immunology, Lymphoma and Oncology. His studies examine the connections between Internal medicine and genetics, as well as such issues in Surgery, with regards to Absolute risk reduction and Confidence interval. Henrik Hjalgrim interconnects Odds ratio, Epidemiology, T-cell lymphoma, Case-control study and Lupus erythematosus in the investigation of issues within Risk factor.
His Immunology study incorporates themes from First-degree relatives and Standardized mortality ratio. His Lymphoma research is multidisciplinary, incorporating elements of Virus, Virology, Genome-wide association study and Family history. His Oncology research integrates issues from Chronic lymphocytic leukemia and Pathology.
His scientific interests lie mostly in Internal medicine, Immunology, Epidemiology, Oncology and Lymphoma. His studies in Cancer, Cohort study, Odds ratio, Risk factor and Relative risk are all subfields of Internal medicine research. His study in Cohort study is interdisciplinary in nature, drawing from both Blood transfusion, Surgery, Retrospective cohort study and Cohort.
His Immunology research incorporates elements of Young adult, Allele and Etiology. His Epidemiology research includes elements of Pregnancy, Incidence and Confidence interval. His work carried out in the field of Oncology brings together such families of science as Chronic lymphocytic leukemia and Pathology.
Henrik Hjalgrim spends much of his time researching Internal medicine, Epidemiology, Confidence interval, Oncology and Hazard ratio. His works in Chronic lymphocytic leukemia, Lymphoma, Odds ratio, Body mass index and Confounding are all subjects of inquiry into Internal medicine. In his research on the topic of Chronic lymphocytic leukemia, Genome-wide association study is strongly related with Follicular lymphoma.
His Epidemiology research incorporates themes from Blood donations, Disease, Cohort study and Cohort. His work deals with themes such as Young adult and Proportional hazards model, which intersect with Hazard ratio. His research on Cytokine concerns the broader Immunology.
His primary areas of study are Epidemiology, Mental health, Hazard ratio, Immunology and Quality of life. His Epidemiology study integrates concerns from other disciplines, such as Blood donations, Transfusion medicine, Blood transfusion and Obstetrics. His Immunology research includes themes of Hemochromatosis, Transferrin and Etiology.
Confounding is a subfield of Internal medicine that Henrik Hjalgrim investigates. His Internal medicine study integrates concerns from other disciplines, such as Multiple sclerosis and Genetic variation. His work in Chronic lymphocytic leukemia tackles topics such as Disease which are related to areas like Oncology and Genome-wide association study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
Karin Ekström Smedby;Claire M. Vajdic;Michael Falster;Eric A. Engels.
Blood (2008)
Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
Henrik Hjalgrim;Johan Askling;Klaus Rostgaard;Stephen Hamilton-Dutoit.
The New England Journal of Medicine (2003)
Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype
Karin Ekström Smedby;Henrik Hjalgrim;Johan Askling;Ellen T. Chang.
Journal of the National Cancer Institute (2006)
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.
Karin Ekström;Henrik Hjalgrim;Lena Brandt;Eva Baecklund.
Arthritis & Rheumatism (2003)
Ultraviolet radiation exposure and risk of malignant lymphomas.
Karin Ekström Smedby;Henrik Hjalgrim;Mads Melbye;Anna Torrång.
Journal of the National Cancer Institute (2005)
Birth Weight as a Risk Factor for Childhood Leukemia: A Meta-Analysis of 18 Epidemiologic Studies
Lisa Lyngsie Hjalgrim;Tine Westergaard;Klaus Rostgaard;Kjeld Schmiegelow.
American Journal of Epidemiology (2003)
Risk of Gastric Cancer and Peptic Ulcers in Relation to ABO Blood Type: A Cohort Study
Gustaf Edgren;Henrik Hjalgrim;Klaus Rostgaard;Rut Norda.
American Journal of Epidemiology (2010)
Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project
Lindsay M. Morton;Susan L. Slager;James R. Cerhan;Sophia S. Wang.
Journal of The National Cancer Institute Monographs (2014)
Changing patterns of tonsillar squamous cell carcinoma in the United States.
Morten Frisch;Henrik Hjalgrim;Ane Bonnerup Jæger;Robert J. Biggar.
Cancer Causes & Control (2000)
Birth Weight and Risk for Childhood Leukemia in Denmark, Sweden, Norway, and Iceland
Lisa Lyngsie Hjalgrim;Klaus Rostgaard;Henrik Hjalgrim;Tine Westergaard.
Journal of the National Cancer Institute (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Copenhagen
Karolinska Institute
Statens Serum Institut
Uppsala University
Statens Serum Institut
Stanford University
Simon Fraser University
University of British Columbia
University of Copenhagen
University of California, San Francisco
Wuhan University
Materialize, Inc.
University of Leeds
Sapienza University of Rome
Georgia Institute of Technology
University of Melbourne
Vanderbilt University
University of Granada
New York University
University of Bonn
Miguel Hernandez University
Universität Hamburg
McMaster University
Tallinn University of Technology
National Development and Research Institutes
Ghent University